The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.
about
Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.A doctor's dilemma: choices amidst changeFighting Neisseria meningitidis: past and current vaccination strategies.Novel approaches to Neisseria meningitidis vaccine design.Invasive meningococcal disease in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation
P2860
The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The capsular group B meningoco ...... rience and potential efficacy.
@en
type
label
The capsular group B meningoco ...... rience and potential efficacy.
@en
prefLabel
The capsular group B meningoco ...... rience and potential efficacy.
@en
P2093
P2860
P1476
The capsular group B meningoco ...... rience and potential efficacy.
@en
P2093
Andrew J Pollard
Christina Dold
Christine S Rollier
Leanne Marsay
P2860
P304
P356
10.1517/14712598.2015.983897
P407
P577
2015-01-01T00:00:00Z